Trademark: 90112426
Status Date
Monday, February 13, 2023
Filing Date
Thursday, August 13, 2020
Published for Opposition
Tuesday, November 17, 2020
Abandoned Date
Monday, February 13, 2023
5 pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Feb 13, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 13, 2023
Abandonment - No Use Statement Filed
Jul 2, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 30, 2022
Sou Extension 3 Granted
Jun 30, 2022
Sou Extension 3 Filed
Jun 30, 2022
Teas Extension Received
Dec 24, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 22, 2021
Sou Extension 2 Granted
Dec 22, 2021
Sou Extension 2 Filed
Dec 22, 2021
Teas Extension Received
Jul 10, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 8, 2021
Sou Extension 1 Granted
Jul 8, 2021
Sou Extension 1 Filed
Jul 8, 2021
Teas Extension Received
Jan 12, 2021
Noa E-Mailed - Sou Required From Applicant
Nov 17, 2020
Official Gazette Publication Confirmation E-Mailed
Nov 17, 2020
Published For Opposition
Oct 28, 2020
Notification Of Notice Of Publication E-Mailed
Oct 13, 2020
Approved For Pub - Principal Register
Sep 22, 2020
Teas/Email Correspondence Entered
Sep 21, 2020
Correspondence Received In Law Office
Sep 21, 2020
Teas Response To Office Action Received
Sep 18, 2020
Notification Of Non-Final Action E-Mailed
Sep 18, 2020
Non-Final Action E-Mailed
Sep 18, 2020
Non-Final Action Written
Sep 18, 2020
Assigned To Examiner
Sep 17, 2020
New Application Office Supplied Data Entered
Aug 17, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
